Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.71 (-1.47%)
AAPL   144.22 (-2.63%)
MSFT   241.76 (-2.32%)
META   108.78 (-2.36%)
GOOGL   96.05 (-1.45%)
AMZN   93.95 (+0.58%)
TSLA   182.92 (+0.03%)
NVDA   158.27 (-2.72%)
NIO   10.12 (-0.49%)
BABA   75.88 (+0.50%)
AMD   73.19 (-2.60%)
T   18.82 (-1.57%)
MU   55.75 (-4.55%)
CGC   3.40 (-7.10%)
F   13.73 (-2.49%)
GE   85.47 (-3.03%)
DIS   95.69 (-3.22%)
AMC   7.33 (-2.40%)
PYPL   79.93 (-0.19%)
PFE   49.57 (+0.73%)
NFLX   281.17 (-1.53%)
NYSE:BDX

Becton, Dickinson and - BDX Price Target & Analyst Ratings

$237.34
-0.72 (-0.30%)
(As of 11/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$236.01
$239.35
50-Day Range
$218.29
$251.26
52-Week Range
$215.90
$280.62
Volume
1.68 million shs
Average Volume
1.23 million shs
Market Capitalization
$67.26 billion
P/E Ratio
40.36
Dividend Yield
1.46%
Price Target
$267.70

Becton, Dickinson and Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 8 Analyst Ratings

Consensus Analyst Price Target

$267.70
12.79% Upside
High Prediction$310.00
Average Prediction$267.70
Low Prediction$220.00
TypeCurrent
11/28/21 to 11/28/22
1 Month Ago
10/29/21 to 10/29/22
3 Months Ago
8/30/21 to 8/30/22
1 Year Ago
11/28/20 to 11/28/21
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
5 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$267.70$277.00$277.63$273.63
Predicted Upside12.79% Upside10.58% Upside9.40% Upside10.29% Upside
Get Becton, Dickinson and Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.


BDX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BDX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Becton, Dickinson and Stock vs. The Competition

TypeBecton, Dickinson andMedical CompaniesS&P 500
Consensus Rating Score
2.38
2.66
2.48
Consensus RatingHoldBuyHold
Predicted Upside12.76% Upside756.56% Upside13.64% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
568
62.49%
Underperform Votes
341
37.51%
Avg. Outperform Votes
163
66.26%
Avg. Underperform Votes
83
33.74%
Avg. Outperform Votes
851
68.13%
Avg. Underperform Votes
398
31.87%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/23/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$319.00 ➝ $272.00+15.40%
11/16/2022Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$270.00+21.65%
11/16/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$255.00+14.89%
11/14/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Joanne Wuensch
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Target$227.00 ➝ $220.00-3.37%
11/11/2022William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Brackmann
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
11/10/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$255.00 ➝ $245.00+6.96%
10/11/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$272.00 ➝ $275.00+24.28%
7/18/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$290.00 ➝ $280.00+17.04%
6/24/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Larry Biegelsen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$275.00+13.38%
3/1/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral ➝ Neutral
2/28/2022Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$275.00 ➝ $310.00+13.67%
2/4/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Antalffy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetMarket Perform$270.00 ➝ $275.00+1.63%
8/6/2021JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral$276.93 ➝ $265.00+9.02%
5/24/2021Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageEqual Weight$270.00+10.78%
1/29/2021Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$270.00 ➝ $282.00+7.69%
8/10/2020UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$265.00 ➝ $280.00+8.86%
5/12/2020KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Matthew Mishan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
5/8/2020Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$285.00 ➝ $278.00+8.33%
(Data available from 11/28/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












BDX Price Target - Frequently Asked Questions

What is Becton, Dickinson and's consensus rating and price target?

According to the issued ratings of 8 analysts in the last year, the consensus rating for Becton, Dickinson and stock is Hold based on the current 1 sell rating, 3 hold ratings and 4 buy ratings for BDX. The average twelve-month price prediction for Becton, Dickinson and is $267.70 with a high price target of $310.00 and a low price target of $220.00. Learn more on BDX's analyst rating history.

Do Wall Street analysts like Becton, Dickinson and more than its competitors?

Analysts like Becton, Dickinson and less than other Medical companies. The consensus rating for Becton, Dickinson and is Hold while the average consensus rating for medical companies is Buy. Learn more on how BDX compares to other companies.

Do MarketBeat users like Becton, Dickinson and more than its competitors?

MarketBeat users like Becton, Dickinson and less than other Medical companies. 62.49% of MarketBeat users gave Becton, Dickinson and an outperform vote while medical companies recieve an average of 66.26% outperform votes by MarketBeat users.

Does Becton, Dickinson and's stock price have much upside?

According to analysts, Becton, Dickinson and's stock has a predicted upside of 11.91% based on their 12-month price targets.

What analysts cover Becton, Dickinson and?

Becton, Dickinson and has been rated by Citigroup, Cowen, Evercore ISI, Morgan Stanley, Piper Sandler, The Goldman Sachs Group, and William Blair in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:BDX) was last updated on 11/28/2022 by MarketBeat.com Staff